Abstract:Abstract Background Standalone nucleic acid amplification tests (NAATs) are increasingly used to diagnose Clostridium difficile infections (CDI), although they may be unable to distinguish colonization from disease. A two-stage algorithm pairing NAAT with a toxin immunoassay (Toxin) has been proposed to improve specificity. We sought to evaluate clinical outcomes among patients testing NAAT+/Toxin+ vs NAAT+/Toxin- by conducting a systematic review and meta-analysis. We further compared outcomes between NAAT+/Toxin- patients who were and were not treated. Methods We searched EMBASE and MEDLINE from inception to September 17, 2022 for articles comparing CDI outcomes among symptomatic patients tested by NAAT and Toxin tests. The risk differences (RD) of all-cause mortality and CDI recurrence were computed by random effects meta-analysis between NAAT+/Toxin+ and NAAT+/Toxin- patients, as well as between treated and untreated NAAT+/Toxin- patients. Results Twenty-three observational studies comprising 11749 patients were included. 30-Day all-cause mortality was not significantly different between NAAT+/Toxin+ and NAAT+/Toxin- patients (8.4% vs 6.8%, respectively; RD=0.2%, 95%CI -2.4, 2.9; I2=52.9%). Recurrence at 60 days was significantly higher among NAAT+/Toxin+ (19.8%) vs NAAT+/Toxin- patients (11.0%) (RD=7.7%, 95%CI=4.6, 10.7, I2=37.4%). Among treated compared to untreated NAAT+/Toxin- patients, the all-cause 30-day mortalities were 5.0% and 14.9%, respectively (RD=-9.5%, 95%CI=-15.0, -3.9, I2=0.0%), but 60-day recurrence was not significantly different (11.6% vs 7.0%, respectively; RD=5.3%, 95%CI -1.7, 12.2; I2=47.0%). Conclusion Compared to NAAT+/Toxin- patients, NAAT+/Toxin+ patients had a greater risk of recurrence at 60 days, but not all-cause mortality. Treatment of NAAT+/Toxin- patients was associated with reduced all-cause mortality, but not recurrence. While subject to the limitations of observational studies including the potential for confounding by indication and immortal time bias, these results suggest that treatment of NAAT+/Toxin- patients may be beneficial. A strategy comparing standalone NAAT or staged testing with up front combined NAAT/Toxin testing could be the topic of a randomized controlled trial to determine cost and efficacy. Disclosures All Authors: No reported disclosures

Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples

699. Clinical Outcomes and Management of NAAT-Positive/Toxin-Negative Clostridium difficile Infection: A Systematic Review and Meta-Analysis

Nationwide Survey for Current Status of Laboratory Diagnosis of Clostridioides difficile Infection in Korea

Assessment Of Clostridium Difficile Infections By Quantitative Detection Of Tcdb Toxin By Use Of A Real-Time Cell Analysis System

Ultrasensitive and Quantitative Toxin Measurement Correlates With Baseline Severity, Severe Outcomes, and Recurrence Among Hospitalized Patients With Clostridioides difficile Infection

Laboratory diagnosis of Clostridioides dif f icile infection: guidelines and status of practice in Korea

Impacts of Infection with Different Toxigenic Clostridium Difficile Strains on Faecal Microbiota in Children.

Identification of toxemia in patients with Clostridium difficile infection

Risk Factors, Outcomes and Epidemiology Associated with Clostridium Difficile Infection in Patients with Haematological Malignancies in a Tertiary Care Hospital in China

Molecular Characterization and Antibiotic Resistance of Clostridioides Difficile in Patients with Inflammatory Bowel Disease from Two Hospitals in China

Molecular Characterization and Antibiotic Profile of Clostridium Difficile Isolated from Bacteremia

The Strain and Clinical Outcome of Clostridioides difficile Infection: A meta-analysis

Molecular Epidemiology of Clostridium Difficile in A Tertiary Hospital of China

Clostridium Difficile Colonization and Infection in Patients with Hepatic Cirrhosis

Disordered Intestinal Microbial Communities During Clostridioides difficile Colonization and Subsequent Infection of Hepatic Cirrhosis Patients in a Tertiary Care Hospital in China

Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population

Rapid discrimination between clinical Clostridioides difficile infection and colonization by quantitative detection of TcdB toxin using a real-time cell analysis system

Diagnostic Guidance for C. difficile Infections

Stool interleukin-1β differentiates Clostridioides difficile infection from asymptomatic carriage and non- C.difficile infection diarrhea

The role of toxin A and toxin B in Clostridium difficile infection

Impact of the Introduction of a Two-Step Laboratory Diagnostic Algorithm in the Incidence and Earlier Diagnosis of Clostridioides difficile Infection